Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the world.</li><li>Through its proprietary TAAP technology Ensysce is in the process of receiving approval for an abuse-resistant yet still pain-relieving opioid.</li><li> The company released 1Q2025 financial data and reminded investors that 2025 is looking to be a potentially pivotal year for ENSC.</li></ul>

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the world.Through its proprietary TAAP technology Ensysce is in the process of receiving approval for an abuse-resistant yet still pain-relieving opioid. The company released 1Q2025 financial data and reminded investors that 2025 is looking to be a potentially pivotal year for ENSC.

Ensysce Biosciences

ENSC: Pivotal Year Off to Good Start